KPC Pharmaceuticals

KPC Pharmaceuticals Current Liabilities

The Current Liabilities of KPC Pharmaceuticals (600422.SS) as of Nov 4, 2026 is 3.83 B CNY. In the previous year, Current Liabilities was 6.98 B CNY — a change of -45.22% (lower).

Current Liabilities

3.83 BCNY

YoY

-45.22%

Last updated:

Current Liabilities of KPC Pharmaceuticals is 2025 3.83 B CNY. Current Liabilities of KPC Pharmaceuticals was 2024 6.98 B CNY. It decreases by -45.22% lower compared to the previous year.

The KPC Pharmaceuticals Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
2.48 B CNY
Jan 1, 2019
3.67 B CNY
Jan 1, 2020
2.45 B CNY
Jan 1, 2021
2.89 B CNY
Jan 1, 2022
4.92 B CNY
Jan 1, 2023
5.36 B CNY
Jan 1, 2024
6.98 B CNY
Jan 1, 2025
3.83 B CNY
The KPC Pharmaceuticals Current Liabilities history
YEARCurrent LiabilitiesYoY
3.83 BCNY-45.22%
6.98 BCNY+30.41%
5.36 BCNY+8.91%
4.92 BCNY+70.39%
2.89 BCNY+17.63%
2.45 BCNY-33.16%
3.67 BCNY+47.94%
2.48 BCNY+133.42%
1.06 BCNY-23.09%
1.38 BCNY+90.30%
726.17 MCNY-38.59%
1.18 BCNY+16.64%
1.01 BCNY-8.36%
1.11 BCNY+52.72%
724.38 MCNY+23.87%
584.80 MCNY+27.66%
458.07 MCNY+0.97%
453.68 MCNY-21.90%
580.92 MCNY+18.47%
490.37 MCNY-20.14%
614.04 MCNY+40.47%
437.13 MCNY+61.19%
271.19 MCNY+42.35%
190.51 MCNY+1.14%
188.37 MCNY-15.68%
223.39 MCNY-29.06%
314.89 MCNY+20.78%
260.70 MCNY+69.98%
153.38 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KPC Pharmaceuticals Stock analysis

What does KPC Pharmaceuticals do? KPC Pharmaceuticals, Inc. generates revenue through the research, development, manufacturing, and international marketing of its diverse drug portfolio. The company sells natural herbal medicines, traditional Chinese medicines, and chemical synthetic drugs, including central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines, and anti-inflammatory drugs. Its main customers are healthcare providers, hospitals, and pharmaceutical distributors globally. The firm also produces health products and offers medical services as additional revenue streams. The company's product segments are defined by therapeutic categories such as central nervous system treatments, cardiovascular care, and anti-inflammatory solutions. These products target both domestic and international markets, with a focus on traditional Chinese medicine and natural herbal formulations. Sales are driven by wholesale distribution networks and direct commercial partnerships in the pharmaceutical industry. KPC Pharmaceuticals' revenue model combines product sales from its core drug lines with supplementary health product offerings and medical service provision. The business leverages its manufacturing capabilities in Kunming, Yunnan to serve global markets, with a strong emphasis on traditional Chinese medicine and natural herbal medicine segments. The firm's international marketing efforts support its presence in multiple regions. KPC Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KPC Pharmaceuticals stock

Current Liabilities of KPC Pharmaceuticals is 3.83 B CNY in 2025.

Current Liabilities of KPC Pharmaceuticals changed from 6.98 B CNY to 3.83 B CNY, representing a -45.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities KPC Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's KPC Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — KPC Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — KPC Pharmaceuticals